Medicare told to reassess premium hike for Alzheimer’s drug

January 10, 2022

U.S. health secretary Xavier Becerra on Monday ordered Medicare to reassess a big premium increase facing millions of seniors this year, attributed in large part to a pricey new Alzheimer’s drug with questionable benefits.

Severe maternal complications at childbirth: A recurring hazard?
About 1–3% of women who give birth in Canada experience serious complications during childbirth such as severe hemorrhage or severe preeclampsia. After surviving these complications (collectively termed "severe maternal morbidity"), many of these women may wish to conceive again in the future but would want to understand the risk associated with a new pregnancy and delivery.
New guidance to support NHS staff after the suicide of a colleague
Researchers from the University of Surrey, University of Birmingham, and Keele University gathered evidence and data over the course of two years, as part of a study which has informed a robust set of new evidence-based postvention guidance to support NHS staff after the death by a suicide of a colleague.
Menstrual leave, neurodiversity, chronic illnesses: What if workplaces adapted to our bodies?
With schools due to reopen soon, many of us will also be returning to work after the summer holidays. For those suffering from health issues especially, the past weeks will have provided a well-needed break from the daily grind, or what the French would colorfully refer to métro-boulot-dodo (metro-work-sleep).
More cities address 'shade deserts' as extreme heat triggers health issues
If it weren't for the traffic along South MacDill Avenue, Javonne Mansfield swears you could hear the sizzle of a frying pan.
Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers
A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer. Scientists in the Perelman School of Medicine at the University of Pennsylvania have demonstrated the potential efficacy of this approach in preclinical tests.

Medicare told to reassess premium hike for Alzheimer’s drug

Recent Posts

JUST IN